Generic drug exclusivity periods vary widely by country, affecting when affordable versions hit the market. The U.S. offers complex protections including 180-day exclusivity for first challengers, while the EU uses a fixed 8+2+1 model. These rules shape global drug prices and access.
Tag: drug patent expiry
